七彩化學(300758.SZ):兩個募投項目延期
格隆匯 3 月 22日丨七彩化學(300758.SZ)公佈,公司考慮目前募投項目的實際進展情況,在募投項目實施主體、實施方式、募集資金投資用途及投資規模不發生變更的前提下,擬對項目達到預定可使用狀態的時間進行調整,調整後募投項目的達到預定可使用狀態日期如下:“高效清潔催化芳腈系列產品及高耐氣候牢度有機顏料擴建項目(第一期)”調整後項目達到預定可使用狀態時間為2021年9月30日;“自動化與信息化擴建項目”調整後項目達到預定可使用狀態時間為2021年12月31日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.